Researchers at NYU Langone’s Vaccine Center use state-of-the-art methods to tackle complex problems in vaccine research. Our basic science and clinical research studies are designed to produce innovative new vaccines and devise ways to make their delivery painless and effective.

In response to the COVID-19 pandemic, we successfully led the development of effective vaccines and treatments to combat infection with SARS-CoV-2, the virus that causes COVID-19. In addition to COVID-19, communities in New York City and around the world are devastated by infectious diseases such as influenza, mpox, tuberculosis, malaria, and HIV/AIDS, conditions that are resistant to many existing drugs and targeted vaccines. Our challenge is to find new ways to combat these diseases and to identify safe, broadly effective vaccines that can make a powerful difference in global health.

We are also interested in developing novel vaccines for nonviral and nonmicrobial illnesses including Alzheimer’s disease, autoimmune diseases, opioid use disorder, cancers, and other chronic conditions.

Beyond vaccine development, we lead research projects to develop new diagnostics and predictive markers to help providers detect disease early and predict the effectiveness of inoculation.

Learn about our recent and past studies by reading our comprehensive research summaries and exploring our recent publications.